Abstract: Epidemiological studies have revealed that a diet rich in plant-derived foods has a protective effect on human health. Identifying bioactive dietary constituents is an active area of scientific investigation that may lead to new drug discovery. Kaempferol (3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one) is a flavonoid found in many edible plants (e.g. tea, broccoli, cabbage, kale, beans, endive, leek, tomato, strawberries and grapes) and in plants or botanical products commonly used in traditional medicine (e.g. Ginkgo biloba, Tilia spp, Equisetum spp, Moringa oleifera, Sophora japonica and propolis). Some epidemiological studies have found a positive association between the consumption of foods containing kaempferol and a reduced risk of developing several disorders such as cancer and cardiovascular diseases. Numerous preclinical studies have shown that kaempferol and some glycosides of kaempferol have a wide range of pharmacological activities, including antioxidant, anti-inflammatory, antimicrobial, anticancer, cardioprotective, neuroprotective, antidiabetic, anti-osteoporotic, estrogenic/antiestrogenic, anxiolytic, analgesic and antiallergic activities. In this article, the distribution of kaempferol in the plant kingdom and its pharmacological properties are reviewed. The pharmacokinetics (e.g. oral bioavailability, metabolism, plasma levels) and safety of kaempferol are also analyzed. This information may help understand the health benefits of kaempferol-containing plants and may contribute to develop this flavonoid as a possible agent for the prevention and treatment of some diseases.
INTRODUCTION
Flavonoids are a group of plant secondary metabolites characterized by a diphenylpropane structure. They are widely distributed in the plant kingdom and are common constituents of fruits, vegetables and some beverages. Flavonoids may play a role in the decreased risk of chronic diseases associated with a diet rich in plant-derived foods. A positive relationship between the ingestion of foods containing flavonoids and a reduced risk of developing cancer and cardiovascular diseases has indeed been observed in some epidemiological studies [1] [2] [3] [4] [5] . In vitro and in vivo investigations have shown plausible mechanisms by which flavonoids may confer cancer and cardiovascular protection [6] . Evidence also suggests that certain flavonoids may be useful in the treatment of several diseases [7] [8] [9] [10] [11] [12] . Some of this evidence comes from the study of plants used in traditional medicine to treat a wide range of pathologies, which has revealed that flavonoids are common bioactive constituents of these plants [10] .
The flavonoid kaempferol (3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one) is a yellow compound with a low molecular weight (MW: 286.2 g/mol) that is commonly found in plant-derived foods and in plants used in traditional medicine. Although there are over two thousand articles in PubMed reporting the isolation and/or biological properties of this flavonoid, there is not any report summarizing or analyzing all this information. The purpose *Address correspondence to this author at the Department of Pharmacology, Faculty of Pharmacy. University of Seville, C/ Profesor García González, nº 2, 41012, Sevilla, Spain; Tel: +34 954 55 63; Fax: +34 954 23 37 65; E-mail: mlopezlazaro@us.es of this article is to review the distribution and biological activities of kaempferol. First we show a compilation of plant species and foods where kaempferol and/or glycosides of kaempferol have been identified. Then, after reviewing the epidemiological evidence linking the consumption of kaempferol-containing foods to the incidence of several diseases, we provide an overview of the pharmacological and toxicological properties of this polyphenol. Finally, we analyze the bioavailability and metabolism of kaempferol, which may help identify which of the many biological activities of this flavonoid may be relevant in an in vivo situation. This information may help understand the preventive and therapeutic properties of kaempferolcontaining plants and may help develop this flavonoid as a possible agent for the prevention and treatment of some diseases. biosynthesis of kaempferol are relatively common in the plant kingdom, it is not surprising that this flavonoid is widely distributed in plants. Sugars such as glucose, rhamnose, galactose and rutinose are usually bound to kaempferol to form glycosides. Some glycosides of kaempferol are very common in nature (e.g. kaempferol-3-O-glucoside, also called astragalin), because their biosynthesis only requires additional enzymes that are widespread in the plant kingdom (e.g. flavonol 3-Oglucosyltransferase, EC 2.4.1.91). The enzymes involved in the biosynthesis of some other kaempferol glycosides are more restricted in nature and, therefore, these glycosides will only be synthesized by plant species with the genetic information required to code for such enzymes. For instance, kaempferol-3-(p-coumaroyltriglucoside) is not widely distributed in plants, as its biosynthesis requires the presence of three additional enzymes that are not widespread: flavonol-3-O-glucoside glucosyltransferase (EC 2.4.1.239), flavonol-3-O-diglycoside glucosyltransferase (EC 2.4.1.240) and flavonol-3-O-triglucoside p-coumaroyltransferase (EC 2.3.1.173). Table 1 compiles plant species in which kaempferol and/or kaempferol glycosides have been identified. This table contains over 400 plant species and shows the botanical family, the type of glycoside and the bibliographical reference. Fig. (2) shows the structure of kaempferol and selected glycosides of kaempferol.
Kaempferol has been identified in many botanical families and has been found in Pteridophyta, Pinophyta and Magnoliophyta. In Pteridophyta, kaempferol and/or some of its glycosides have been identified in Aspidiaceae, Aspleniaceae, Blechnaceae, Cyatheaceae, Dennstaedtiaceae, Equisetaceae, Ophioglossaceae, Polypodiaceae and Schizaeaceae (see Table 1 
Species

Family Compounds Reference
Epimedium sagittatum Berberidaceae Kaempferol, kaempferol 3-O-(2''-E-p-coumaroyl,4''-Z-p-coumaroyl)--L-rhamnopyranoside and kaempferol 3-O-(3''-Z-p-coumaroyl,4''-Ep-coumaroyl)--L-rhamnopyranoside [496, 497] Equisetum arvense Equisetaceae Kaempferol 3-O-glucoside [498] Equisetum debile Equisetaceae Kaempferol 3-O-sophoroside, kaempferol 3,7-O--D-diglucopyranoside and kaempferol 3-O-sophoroside-7-O--Dglucopyranoside [499] Equisetum myriochaetum Equisetaceae Kaempferol glucosides [248] Equisetum palustre Equisetaceae Kaempferol 3-O-1''--D -glucopyranosyl-3-O-1'''--Dglucopyranoside [500] Eriobotrya japonica Rosaceae Kaempferol 3-rhamnosides [501] Eruca sativa Brassicaceae Kaempferol and kaempferol glycosides [410] Eucalyptus spp Myrtaceae Kaempferol [502] Eucalyptus occidentalis Myrtaceae 6,8-di-C-methylkaempferol 3-methyl ether [177] Euonymus alatus Celastraceae Kaempferol [260] Euphorbia aleppica Euphorbiaceae Kaempferol [503] 
Euphorbia pekinensis Euphorbiaceae Kaempferol 3-O-(2"-O-galloyl)--D-glucoside [221]
Euphorbia petiolata Euphorbiaceae Kaempferol 3-O-(2-O-galloyl)-glucoside, kaempferol 3-O-glucoside and kaempferol 3-O-rhamnoside [504]
Euscaphis Japonica Staphyleaceae Kaempferol and kaempferol 3-O--D-glucopyranoside [505] Evolvulus alsinoides Convolvulaceae Fagonia arabica Zygophyllaceae Kaempferol 7-O-rhamnoside [508] Fagonia taeckholmiana Zygophyllaceae Kaempferol 3-O-glucoside, kaempferol 3,7-di-O-rhamnoside and kaempferol 3-O--L-arabinopyranosyl-(1 4)--L-rhamnopyranoside-7-O--L-rhamnopyranoside [509] Ficaria verna Ranunculaceae Kaempferol 3-O--D-(6"--L-rhamnopyranosyl)-glucopyranoside (nicotiflorin) [510] Ficus pandurata Moraceae Kampferol 3-O--neohesperidoside [511] Foeniculum vulgare Apiaceae Kaempferol 3-O-rutinoside and kaempferol 3-O-glucoside [512] Forsteronia refracta Apocynaceae Kaempferol 3-O-(2'',4''-O-di-acetyl--L-rhamnopyranoside), kaempferol 3-O-(3'',4''-O-diacetyl--L-rhamnopyranoside) and kaempferol 3-O-(4''-O-acetyl--L-rhamnopyranoside) [ 
513]
Fragaria ananassa Rosaceae Kaempferol 3--D-(6-O-trans-p-coumaroyl)glucopyranoside and kaempferol 3--D-(6-O-cis-p-coumaroyl)glucopyranoside [514, 515] Frankenia laevis Frankeniaceae Kaempferol 3,7-di-sodium sulphate [516] [300]
Hedyotis diffusa Rubiaceae Kaempferol 3-O-(2-O--D-glucopyranosyl)--D-galactopyranoside and kaempferol 3-O-[2-O-(6-O-E-feruloyl)--D-glucopyranosyl]--Dgalactopyranoside [281]
Helichrysum italicum Asteraceae Kaempferol 3-O--D-(6"-E-p-coumaroyl)-glucopyranoside (tiliroside) [527] Helleborus niger Ranunculaceae Kaempferol 3-O--L-arabinopyranosyl-(1 2)--Dgalactopyranoside-7-O--D-glucopyranoside [528] Hemerocallis spp Hemerocallidaceae Kaempferol 3-O-glycoside [529] Heterotheca inuloides Asteraceae Kaempferol [530] Hippophae rhamnoides Elaeagnaceae Kaempferol [531] Hosta ventricosa Hostaceae Kaempferol glycosides [532] Hydrangea macrophylla Hydrangeaceae Kaempferol oligoglycosides [533] Hypericum brasiliense Clusiaceae Kaempferol [534] Hypericum perforatum Clusiaceae Kaempferol [535] Ilex pernyi Aquifoliaceae Kaempferol 3-O-sambubioside [536] Impatiens balsamina Balsaminaceae Kaempferol, kaempferol 3-glucoside, kaempferol 3-glucosylrhamnoside, kaempferol 3-rutinoside and kaempferol 3-(pcoumaroyl)glucoside
[210, 537, 538] Impatiens textori Balsaminaceae Kaempferol, kaempferol 3-glucoside and kaempferol 3-rhamnosyldiglucoside [539] Indigofera hebepetala 
Species Family Compounds Reference
Indigofera suffruticosa Leguminosae Kaempferol [541] Indigofera truxillensis Leguminosae Kaempferol [541] Ixeridium gracile Asteraceae Kaempferol [542] Kalanchoe pinnata
Kanahia laniflora Lactuca scariola Asteraceae Kaempferol [548] Lamium album Lamiaceae Kaempferol 3-O-glucoside [549] Lamium amplexicaule
Laurus nobilis
Lavatera trimestris Malvaceae Kaempferol 7-O--D-glucoside and kaempferol 3-O--D-glucoside [551] Leonurus persicus Lamiaceae Kaempferol 3-O-glucoside [552] Leptothyrsa sprucei Rutaceae Kaempferol 3-O--L-rhamnopyranoside [553] Licania licaniaeflora Chrysobalanaceae Kaempferol 3-O--rhamnoside [554] Ligustrum sinense
Lilium candidum Liliaceae Kaempferol [556] Lilium longiflorum Liliaceae Kaempferol and kaempferol glycosides [557] Lilium pumilum Liliaceae Kaempferol 3-O-rutinoside [558] Lonicera japonica
Loranthus tanakae
Lotus polyphyllos Leguminosae Kaempferol 3,7-di-O-glucosides and kaempferol 3-O--(6"-O-E-pcoumaroylglucoside)-7-O--glucoside [560] Lycium barbarum Solanaceae Kaempferol, kaempferol 3-O-rutinoside and kaempferol 3-Orutinoside-7-O-glucoside [561, 562] Lygodium Flexuosum Schizaeaceae Kaempferol, kaempferol 3--D-glucoside [563] Lysimachia vulgaris Primulaceae Heterosides derivatives of kaempferol [564] Machilus philippinensis Lauraceae Kaempferol 3-O--L-rhamnopyranoside 3'',4''-di-E-P-coumaroic acid ester and kaempferol 3-O--L-rhamnopyranoside 3''-E,4''-Z-di-pcoumaroic acid ester [565] Magnolia fargesii Magnoliaceae Kaempferol 3-O--D-(6"-O-coumaroyl)glucopyranoside (tiliroside) [566] ( Table 1) . Contd…..
Malva crispa Malvaceae Kaempferol glycosides [567] Malus domestica Rosaceae Kaempferol 3-O-rhamnoside [568] Manihot esculenta Euphorbiaceae Kaempferol 3-O-rutinoside [569] Maytenus aquifolium
Maytenus ilicifolia
galactopyranoside and other kaempferol glycosides [571] Meconopsis spp Papaveraceae
Meconopsis quintuplinervia
Melastoma malabathricum
Melilotus neapolitana Leguminosae Kaempferol 3-O-rutinoside and kaempferol 3-O-glucoside [575] Miconia cabucu
Mitracarpus scaber Rubiaceae Kaempferol 3-O-rutinoside [577] Monnina sylvatica 
Morus alba
Morus insignis Moraceae Kaempferol 3-O--glucopyranoside [253] Musa spp Musaceae Kaempferol 3-O-rutinoside [586] Nelumbo nucifera Nelumbonaceae Kaempferol and kaempferol glycosides [98, 587] Neocheiropteris palmatopedata Polypodiaceae Kaempferol glycosides [588] Nepenthes gracilis Nepenthaceae Kaempferol [589] Nephelium lappaceum
Nicotiana tabacum Solanaceae Kaempferol 3-rutinoside [591] Nymphaea candida
Nymphaea odorata Nymphaeaceae Kaempferol 3-O--l-rhamnopyranoside [592] Ochna beddomei Ochnaceae Kaempferol, kaempferol 3-O-rhamnoside and kaempferol 3-Oglucoside [593] ( Table 1) . Contd…..
Species Family Compounds Reference
Ochradenus baccatus Resedaceae Kaempferol 3-O--D-glucopyranoside (astragalin) [594] Olea europaea Oleaceae Kaempferol [595] Ophioglossum petiolatum Ophioglossaceae Kaempferol [596] Opuntia dillenii
Opuntia ficus-indica Cactaceae Kaempferol, kaempferol 3-methyl ether [598] Origanum dictamnus Lamiaceae Kaempferol [599] Orostachys japonicus Crassulaceae Kaempferol [600] Oxytropis falcate Leguminosae Kaempferol [601] Paeonia suffruticosa Paeoniaceae Kaempferol 7-O-glucoside [602] Papaver nudicaule Papaveraceae Kaempferol 3-O--sophoroside, kaempferol 3-O--sophoroside-7-O--glucoside and other kaempferol derivatives [603] Parthenocissus tricuspidata Vitaceae Kaempferol and kaempferol 3,5,7,4'-O-tetramethyl [604] Pedilanthus tithymaloides Euphorbiaceae Kaempferol 3-O--D-glucopyranoside-6''-(3-hydroxy-3-methylglutarate) [ 
605]
Pelargonium quercifolium Geraniaceae Kaempferol [606] Pemphis acidula Lythraceae Kaempferol 6"-O-galloyl--D-glycosides [607] Pentachondra pumila Epacridaceae Kaempferol 3-(2,4-di-E-p-coumaroylrhamnoside) [608] Persicaria lapathifolia
Peumus boldus Monimiaceae Kaempferol glycosides [610] Phaleria macrocarpa Thymelaeaceae Kaempferol 3-O--D-glucoside [611] Phaseolus vulgaris Leguminosae Kaempferol 3-O-[xylosyl-(1 2)]-rhamnosyl-(1 6)-glucoside, kaempferol 3-O-glucuronide, kaempferol 3-O--D-glucopyranoside and kaempferol 3-O-rutinoside [612, 613] Phellodendron amurense Rutaceae Kaempferol 3-O--D-glucoside [614] Phlomis aurea
Phlomis caucasica Lamiaceae Kaempferol 3-O-glucoside [616] Phyllanthus acidus Euphorbiaceae Kaempferol [617] Phyllanthus emblica
Phytolacca americana
Pinus densiflora Pinaceae Kaempferol 3-O--D-glucoside and 6-C-methyl kaempferol 3-O--Dglucoside [620] Pistacia vera Anacardiaceae Kaempferol [621] Pisum sativum Leguminosae Kaempferol 3-sophorotrioside [622] [677] 
Sauropus androgynus
Securinega virosa
Euphorbiaceae Kaempferol 3-O-(4-galloyl)--D-glucopyranoside [684] Sedum dendroideum Crassulaceae Kaempferol 3--O-rhamnopyranosyl-(1 2)--glucopyranoside-7-O- -glucopyranoside, kaempferol 3-O--rhamnopyranosyl-(1 2)-- glucopyranoside-7-O--rhamnopyranoside, kaempferol 3,7-O--di- rhamnoside (kaempferitrin) and kaempferol 3-O--glucopyranoside-7- O--rhamnopyranoside [302]
Sedum sarmentosum
Crassulaceae Kaempferol 3--arabinopyranoside [233] Senecio scandens Asteraceae Kampferol 3-O-rhamnoside [685] Silphium perfoliatum
Simarouba versicolor Simaroubaceae Kaempferol [687] Siparuna apiosyce Monimiaceae Kaempferol glycosides [688, 689] Siraitia grosvenori
Smilax bockii Smilacaceae Kaempferol and kaempferol 7-O--D-glucopyranoside [691] Smilax china Smilacaceae Kaempferol 7-O--D-glucoside [182, 187] Solanum lycopersicum Solanaceae Kaempferol, kaempferol 3-O-sophoroside and kaempferol 3-Orutinoside [692] [693] [694] Solanum nigrum Solanaceae Kaempferol [695] Solenostemma argel Asclepiadaceae Kaempferol 3-O--rhamnopyranosyl-(1 2)--glucopyranoside [696] Solidago altissima
Solidago virga-aurea Asteraceae Kaempferol and kaempferol 3-O-rutinoside [698] ( 
Species
Family Compounds Reference
Sophora japonica
Spiraea canescens Rosaceae 6'-O-(4''-methoxy-trans-cinnamoyl)-kaempferol-3--Dglucopyranoside [704] Spiranthes australis
Stenochlaena palustris
Stocksia brauhica
Sutherlandia frutescens
Leguminosae
Symplocarpus renifolius
Syzygium aromaticum Myrtaceae Kaempferol [711] Tadehagi triquetrum Leguminosae Kaempferol [712] Tamarix nilotica Tamaricaceae Kaempferol 4'-methyl ether [713] Taxus baccata Taxaceae Kaempferol and 7-O-glucosides kaempferol [22] Tephrosia calophylla
Terminalia myriocarpa
Ternstroemia japonica Theaceae Kaempferol derivative [716] Tetrapanax papyriferus
Theobroma grandiflorum Sterculiaceae Kaempferol [718] Thesium chinense Santalaceae Kaempferol and kaempferol 3-O-glucoside [719] Thevetia peruviana Apocynaceae Tilia tomentosa Tiliaceae Kaempferol [723] Tribulus terrestris Zygophyllaceae Kaempferol 3-gentiobioside [724] Trifolium alexandrinum Leguminosae Kaempferol [725] Trifolium resupinatum Leguminosae Kaempferol glycosides [726] Trigonella foenum-graecum
Tulipa gesneriana Liliaceae Kaempferol 7-O-glucuronides [728] Ullucus tuberosus
Uvaria tonkinensis
Vaccinium vitis-idaea Ericaceae Kaempferol-pentoside, kaempferol-deoxyhexoside and kaempferol 3-
Vahlia capensis Vahliaceae Kaempferol [732] Vernonia ferruginea Asteraceae Vicia faba Leguminosae Kaempferol 3-O-galactoside,7-O-rhamnoside [735] Vinca minor Apocynaceae Kaempferol glycosides [736] Viola tricolor Violaceae Kaempferol glycosides [737] Vismia laurentii Clusiaceae Kaempferol [738] Vitis rotundifolia Vitaceae Kaempferol glycosides [739] Vitis vinifera Vitaceae Kaempferol, kaempferol 3-glucoside, kaempferol 3-galactoside and kaempferol 3-glucuronide [740] Waltheria indica
Warburgia stuhlmannii Canellaceae Kaempferol, kaempferol 3-O--L-rhamnopyranoside and kaempferol 7-O--D-glucopyranoside [742] Warburgia ugandensis Canellaceae Kaempferol 3-O--rhamnoside-7,4'-di-O--galactoside, kaempferol 3,7,4'-tri-O--glucoside, kaempferol, kaempferol 3-rhamnoside, kaempferol 3-rutinoside, kaempferol 3-arabinoside, kaempferol 3-rhamnoside-4'-galactoside and kaempferol 3-glucoside [743] Zelkova oregoniana Ulmaceae Kaempferol [744] Zingiber aromaticum Liliaceae, Musaceae, Orchidaceae, Poaceae, Smilacaceae and Zingiberaceae (see Table 1 for references). In Dicotyledons, kaempferol has been identified in numerous families, including Actinidiaceae, Alangiaceae,Moraceae, Moringaceae, Myrsinaceae, Myrtaceae, Nelumbonaceae, Nepenthaceae, Nyctaginaceae, Nymphaeaceae, Ochnaceae, Oleaceae, Paeoniaceae, Papaveraceae, Phytolaccaceae, Platanaceae, Polygalaceae, Polygonaceae, Primulaceae, Punicaceae, Ranunculaceae, Resedaceae, Rhamnaceae, Rhizophoraceae, Rosaceae, Rubiaceae, Rutaceae, Salicaceae, Santalaceae, Sapindaceae, Saxifragaceae, Scrophulariaceae, Simaroubaceae, Solanaceae, Staphyleaceae, Sterculiaceae, Tamaricaceae, Theaceae, Thymelaeaceae, Tiliaceae, Ulmaceae, Vahliaceae, Violaceae, Vitaceae and Zygophyllaceae (see Table 1 
BIOLOGICAL ACTIVITIES OF KAEMPFEROL
Epidemiological Studies
The possible association between the consumption of foods containing kaempferol and a reduced risk of developing several disorders, including cancer and cardiovascular diseases, has been evaluated in several epidemiological studies. Some case-control (retrospective) and cohort (prospective) studies have evaluated the relationship between consumption of kaempferol-rich foods and the risk of developing several types of cancer. Cui et al.
[25] conducted a case-control study of 558 lung cancer cases and a group of 837 controls, and observed that the consumption of kaempferol-rich foods (i.e. tea, beans, broccoli, spinach, apples and strawberries; approximately 2 mg kaempferol/day) was inversely associated with lung cancer risk (OR= 0.68; 95% CI: 0.51-0.90); this association was less clear among non-smokers. A case-control study conducted in Spain with 103 cases and 206 hospital controls also reported a positive association between high intake of kaempferol and a lower incidence of lung cancer (OR = 0.51; 95% CI: 0.22-1.17), although this association was not significant [26] . García-Closas et al. carried out a casecontrol study with 354 cases of gastric cancer and 354 controls and found that consumption of kaempferolcontaining foods (i.e. onions, cruciferous, green beans, apples, grapes and strawberries) was associated with a reduced gastric cancer risk (OR = 0.48; p for trend = 0.04) [5] . Nöthlings et al.
[27] conducted a cohort study to evaluate the possible association between consumption of kaempferol-containing foods (i.e. onions, tea, apples, cruciferous and other vegetables) and pancreatic cancer risk in 183518 people. After a follow-up period of 8 years, the authors found that kaempferol consumption was inversely associated with pancreatic cancer risk (RR = 0.78; 95% CI: 0.58-1.05; p trend: 0.017; the median intake of kaemmperol was 3.89 mg/day). The correlation between intake of kaempferol-rich foods (i.e. broccoli, kale and tea) and incidence of epithelial ovarian cancer was evaluated in a cohort study in 66940 women. The study found that kaempferol was associated with a significant 40% decrease in epithelial ovarian cancer incidence (RR = 0.60; 95% CI: 0.42-0.87; p for trend: 0.002; median intake was 11 mg kaempferol/day) [28] . This association between kaempferol intake and ovarian cancer risk, however, was not observed in a recent case-control study with 1141 cases and 1183 controls [29] .
Other epidemiological studies did not find a positive correlation between consumption of kaempferol-containing foods and the risk of several other types of cancer. A casecontrol study carried out with 497 cases, 547 neighborhood controls and 566 hospitals controls did not find a reduced bladder cancer risk in people consuming kaempferolcontaining foods [30] . Likewise, McCann et al. [31] conducted a case-control study with 433 prostate cancer cases and 538 population-based controls and did not find a significant association between the consumption of kaempferol-containing foods (i.e. coffee, tea, green peppers, green beans, turnip greens, orange juice and apple juice) and a reduced prostate cancer risk (OR = 0.83; 95% CI: 0.58-1.18; p for trend: 0.80). A prospective study evaluated the association between flavonol-rich foods intake and breast cancer risk in 90630 women [32] and found a similar relative risk of developing breast cancer in the lower (0.80 mg kaempferol/day) and higher (12.9 mg kaempferol/day) quintile (MV RR = 1.01; 95% CI: 0.80-1.27; p for trend: 0.91). Lin et al. [33] evaluated the possible correlation between consumption of kaempferol-containing foods and the risk of colorectal cancer in a prospective study (71976 women and 35425 men) and found no association between increased intake of kaempferol and reduced colorectal cancer risk (RR = 1.12; 95% CI: 0.90-1.39; p for trend 0.25).
Several case-control and cohort studies have evaluated the relationship between consumption of kaempferol-rich foods and the risk of cardiovascular diseases. The possible correlation between flavonoid consumption (quercetin, kaempferol, myricetin, apigenin and luteolin) and mortality from coronary heart disease was studied in a cohort study in 805 men aged 65-84 years [1]. The study found that the consumption of flavonoid-containing foods (i.e. black tea, onions and apples) was associated with a reduced mortality from coronary heart disease (RR = 0.42; 95% CI; p for trend: 0.015) and with a reduced incidence of myocardial infarction (p trend: 0.08). Geleijnse et al. [34] conducted another cohort study in 4807 people followed-up for 5,6 years and observed that a high intake of tea (source of kaempferol) was inversely associated with myocardial infarction (RR = 0.57; 95% CI: 0.33-0.98). The correlation between intake of kaempferol-rich foods and the risk of coronary heart disease was also analyzed in a cohort study in 66360 women followed-up for 12 years [35] . This study found a weak risk reduction for coronary heart disease death among women with a higher intake of kaempferol-containing foods (i.e. broccoli, onions, grapes, apples and tea; RR = 0.66; 95% CI: 0.48-0.93; p trend: 0.04). In a cohort study with 361 men and 394 women aged 65-99 years and followed up for up to 10 years, kaempferol consumption was also associated with a significant decreased relative risk of acute myocardial infarction (RR = 0.481, 95% CI: 0.3-0.77; p trend: 0.002) [36] . The association between flavonoid-containing foods intake (i.e. apples, grapefruit, onions, white cabbage, berries, juices and oranges) and risk of several chronic diseases was assessed in a cohort study in 10054 people [37] . This study showed that the incidence of cerebrovascular disease was lower at higher kaempferol intakes (RR = 0.70; 95% CI: 0.56-0.86; p: 0.003; median intake was 0.5 mg kaempferol/day). These data suggest that consumption of foods containing kaempferol may reduce the risk of developing some cardiovascular disorders.
The correlation between the consumption of kaempferolcontaining foods and the occurrence of type 2 diabetes has been studied in a cohort study [38] . This study included 38018 women aged 45 and free of cardiovascular disease, cancer and diabetes. Although the authors found that none of the tested flavonoids (including kaempferol) was significantly associated with risk of type 2 diabetes, they observed a reduced relative risk of type 2 diabetes in people with an increased intake of the kaempferol-containing foods apples (RR: 0.72; p for trend: 0.006) and tea (RR: 0.73; p for trend: 0.06; 95% CI).
In summary, epidemiological data suggest that a high intake of kaempferol-containing foods may reduce the risk of developing several types of cancers (e.g. lung, gastric, pancreatic and ovarian cancer) and cardiovascular diseases. But the relatively low number of studies and the possible presence of other bioactive constituents in kaempferolcontaining foods (e.g. vitamins, minerals and other phytochemicals) make these data insufficient to draw any conclusion regarding the possible protective effect of kaempferol in these diseases. Numerous experimental data have shown, however, that kaempferol possesses a wide range of biological activities involved in the prevention and treatment of these and other diseases. The biological activities of kaempferol are summarized and analyzed in the following sections.
Antioxidant Activity
We breathe because our cells need oxygen to generate energy in a mitochondrial process called oxidative phosphorylation (oxphos). In this process, the generation of energy in the form of ATP is coupled with a reaction in which oxygen (O 2 ) is reduced to H 2 O. In this reaction, four electrons and four protons are added to O 2 to form two molecules of H 2 O. But when a molecule of O 2 gains only one electron to form superoxide anion (O 2 -), this highly reactive oxygen species (ROS) tends to gain three more electrons and four protons to form H 2 O; this process involves several reactions and results in the production of other ROS such as hydrogen peroxide (H 2 O 2 ), hydroxyl radical and peroxynitrite. The controlled production of ROS has an important physiological role [39] . A high production of ROS that is not counterbalanced by the cellular antioxidant defense, however, increases the cellular levels of ROS and originates oxidative stress. Oxidative stress has been proposed to play an important role in the pathogenesis of cancer, cardiovascular disease, atherosclerosis, hypertension, ischemia/reperfusion injury, diabetes mellitus, neurodegenerative disorders, rheumatoid arthritis, and ageing [40, 41] . Antioxidant agents can reduce oxidative stress and may therefore play a protective role in the development of these processes.
The antioxidant properties of flavonoids are widely acknowledged [42] [43] [44] . Numerous reports have shown that kaempferol, some glycosides of kaempferol, and several kaempferol-containing plants have antioxidant activity not only in vitro, but also in vivo [45] [46] [47] [48] [49] [50] . Several studies have shown that the presence of a double bond at C2-C3 in conjugation with an oxo group at C4, and the presence of hydroxyl groups at C3, C5 and C4', are important structural features involved in the antioxidant activity of kaempferol [42, 58] .
Kaempferol has been found to be a potent superoxide scavenger, with an IC 50 of 0.5 M [51] . The ability of kaempferol to decrease superoxide levels at low concentrations may play an important role in its antioxidant activity, as the formation of superoxide anion is required for the normal production of most reactive oxygen and nitrogen species involved in oxidative stress [52] . Superoxide anion is commonly converted into H 2 O 2 by the enzymes superoxide dismutases. In the presence of reduced transition metals (e.g., ferrous or cuprous ions), H 2 O 2 can be converted into the highly reactive hydroxyl radical. Superoxide anion can also react with nitric oxide to form peroxynitrite. Hydroxyl radical and peroxynitrite are highly reactive species known to cause damage to DNA, proteins and lipids. Interestingly, low concentrations of the flavonol kaempferol have been found to scavenge these two highly reactive species. Wang et al.
[51] evaluated the antioxidant activity of several flavonoids and found that kaempferol was one of the strongest scavengers for the Fenton-generated hydroxyl radical, with an IC 50 of 0.5 M. Likewise, Heijnen et al. [53] observed that kaempferol was a potent peroxynitrite scavenger, with an IC 50 of 0.35 ± 0.5 M.
The ability of kaempferol to decrease superoxide anion, hydroxyl radical and peroxinitrite levels at submicromolar concentrations may play a key role in its antioxidant activity. Kaempferol has also been found to exert antioxidant effects through other mechanisms of action, although most of these effects have been observed at higher concentrations. Kaempferol can inhibit the activity of enzymes that generate ROS, such as the enzyme xanthine oxidase [51, 54, 55] . Like other flavonoids, kaempferol can also reduce the formation of hydroxyl radical through the Fenton's reaction by chelating ferrous or cuprous ions [56] [57] [58] . Kaempferol may also induce antioxidant effects by increasing the expression or activity of antioxidant enzymes such as superoxide dismutase, catalase, and heme oxygenase-1 [59-61]. Other studies have revealed that kaempferol and some glycosides of kaempferol prevent lipid peroxidation [58, 62-69]; the activity of kaempferol is higher than that of its glycosides because kaempferol has a higher lipophilia and capacity to penetrate into lipid bilayers to exert this activity. Kaempferol can also prevent the oxidation of low-density lipoprotein (LDL), which may play a protective role in atherosclerosis [70] [71] [72] [73] [74] .
The antioxidant activity of kaempferol has been observed in several in vivo studies [45] [46] [47] [48] [49] [50] . For instance, kaempferol was found to decrease intracellular ROS accumulation and increase the survival of Caenorhabditis elegans [45] . An extract of Capparis spinosa, which contained kaempferol derivatives, showed a significant antioxidant activity when applied topically in healthy human volunteers [46] . Sanz et al.
[47] treated mice with kaempferol-3-O-galactoside after bromobenzene intoxication and observed that this flavonoid reduced hepatic lipid peroxidation products and increased the levels of reduced glutathione. The intraperitoneal injection of an extract of Crassocephalum crepidioides that contained kaempferol glycosides showed a strong antioxidant effect and prevented galactosamine-and lipopolysaccharideinduced hepatotoxicity in rats [50] . A Ginkgo biloba extract, containing kaempferol and quercetin derivatives, has also been reported to exert antioxidants effects in vivo [48].
Anti-Inflammatory Activity
Inflammation is a physiological process in response to tissue damage resulting from microbial pathogen infection, chemical irritation, and/or wounding. After tissue injury, a multifactorial network of chemical signals initiates and maintains a host response designed to heal the damaged tissue. The activation and migration of leukocytes to the site of damage and the release of growth factors, cytokines and reactive oxygen and nitrogen species are known to play a crucial role in the inflammatory response. Inflammatory processes are required for immune surveillance, optimal repair, and regeneration after injury. When acute inflammation is not resolved, however, chronic inflammation occurs, which has a detrimental effect in several diseases including atherosclerosis, cancer, asthma and some neurological disorders, such as Alzheimer's disease and . ROS are also known to participate in the inflammatory process and, as shown in the previous section, kaempferol can reduce the cellular levels of ROS. In summary, numerous in vitro and in vivo studies have revealed that kaempferol has anti-inflammatory activity and have shown several mechanisms that may participate in this activity.
Anticancer Activity
Epidemiological evidence (case-control and cohort studies) suggests that the consumption of kaempferol-rich foods may reduce the risk of developing some types of cancer, including lung cancer [25, 26] The most accepted view of carcinogenesis (the somatic mutation theory of cancer) considers that cancer is caused by DNA alterations [112] , and several reports suggest that low concentrations of kaempferol may protect DNA from damage induced by different carcinogens [113] [114] [115] [116] . It is widely accepted that the formation of a malignant tumor requires that tumor cells acquire several capabilities (the socalled hallmarks of cancer), such as apoptosis resistance, increased angiogenesis, or capacity of invasion and metastasis [118, 119] . The formation of a cancer requires that tumor cells develop apoptosis resistance, and it has been observed that kaempferol can induce apoptosis [120] [121] [122] [123] [124] [125] [126] [127] . Angiogenesis (the generation of new blood vessels) is necessary for the formation of solid tumors; without vascular growth, the tumor mass is restricted to a tissue-diffusion distance of approximately 0.2 mm. Malignant tumors are known to activate angiogenesis, and kaempferol has been shown to inhibit angiogenesis in vitro [128] [129] [130] . It is recognized that the metastatic spread of primary tumors accounts for approximately 90% of all cancer deaths; the process by which cells from a localized tumor invade adjacent tissues and metastasize to distant organs may therefore be the most clinically relevant process involved in carcinogenesis [131] . Experimental data have revealed that kaempferol may inhibit this process in vitro and/or in vivo [93, [132] [133] [134] .
Accumulating evidence suggests that reactive oxygen species (ROS) have an important role in the development of cancer. The key role of ROS in carcinogenesis is supported by experimental data showing that cancer cells commonly have increased levels of ROS, that ROS can induce cell malignant transformation and that the malignant phenotype of cancer cells can be reversed by reducing the cellular levels of ROS [135] [136] [137] [138] . Because antioxidant agents can prevent the accumulation and/or reduce excessive cellular levels of ROS, they may play a protective role in cancer development. For instance, experimental data revealed that the expression of antioxidant enzymes in malignant cells decreased their cellular levels of ROS; these cells reverted to a normal appearance, their growth rate normalized, and they were no longer capable of producing tumors in athymic mice [137] . These data suggest that the extensively reported antioxidant activity of kaempferol may be a key mechanism by which this dietary flavonoid prevents cancer.
Several lines of research suggest that inflammation plays a significant role in cancer [139] . It is recognized that inflammatory diseases increase the risk of developing many types of cancer, including bladder, cervical, gastric, intestinal, esophageal, ovarian, prostate and thyroid cancer. Inflammatory cells, chemokines and cytokines are also present in the microenvironment of all tumors in experimental animal models and humans from the earliest stages of development. Transfer of inflammatory cells or overexpression of inflammatory cytokines promotes the development of tumors. In addition, the targeting of inflammatory mediators (chemokines and cytokines, such as TNFand IL-1 ), transcription factors involved in inflammation (such as NF-B and STAT3) or inflammatory cells decreases the incidence and spread of cancer. Nonsteroidal anti-inflammatory drugs are also known to reduce the risk of developing certain cancers (such as colon and breast cancer) and reduce the mortality caused by these cancers [139] . These data suggests that the antiinflammatory properties of kaempferol may play an important role in the cancer preventive activity of this flavonoid.
Most chemical carcinogens need to be enzymatically activated to become genotoxic, and the cytochrome P450 (P450) enzymes are the most prominent enzymes involved in such activation [140] . Some studies have shown that kaempferol may inhibit P450 [141, 142] and therefore prevent the activation of carcinogenic agents. Kaemferol has been found to decrease the activation of the naturally occurring mycotoxin aflatoxin in rats [143] . This flavonoid has also been found to act as a potent inhibitor of the aryl hydrocarbon receptor (AhR); this receptor is activated by human carcinogens present in air pollution and cigarette smoke [144] . The authors observed that kaempferol also inhibited the ability of cigarette smoke condensate to induce growth of immortalized lung epithelial cells [144] . Mukai et al. found that oral administration of kaempferol or Ginkgo biloba extract (EGb) containing 24% flavonol at 100 mg/kg body weight suppressed AhR transformation induced by 3-methylcholanthrene in the liver of mice [145] . Kaempferol has also been described as a potent non-competitive inhibitor of sulfotransferase 1A1, an enzyme capable of bioactivating procarcinogens to reactive electrophiles [146] . In addition to inhibiting several phase I enzymes, kaempferol may induce phase II detoxifying enzymes, such as quinone reductase [147] . Kaempferol has also been found to reduce the cellular levels of the carcinogen 7,12-dimethylbenz(a)-anthracene by potently stimulating the P-glycoprotein-mediated efflux of this carcinogen [148] .
Hypoxia-inducible factor 1 (HIF-1) is a key regulator of O 2 homeostasis. The activation of HIF-1 is known to play a vital role in the most relevant aspects of carcinogenesis, including cell survival, angiogenesis, invasion, metastasis, cellular immortalization and metabolic reprogramming [149] [150] [151] . HIF-1 activation is observed in most human cancers and has been associated with increased patient mortality. For instance, Zhong et al. [152] identified increased HIF-1 expression (relative to adjacent normal tissue) in 13 tumor types, including lung, prostate, breast, and colon carcinoma, which are the most common cancers in developed countries. These data suggest that HIF-1 activation is a key event in carcinogenesis and may therefore represent a key target for cancer chemoprevention [153] . Mylonis et al. [154] investigated the effect of kaempferol on activity, expression levels and localization of HIF-1 in hepatoma cancer cells and found that this dietary flavonoid inhibited this transcription factor in the low micromolar range. HIF-1 was also downregulated by kaempferol in ovary cancer cells [155] .
Kaempferol has shown other activities that may be relevant to cancer chemoprevention. The ribosomal S6 kinase 2 (RSK2), a member of the p90(RSK) family of proteins, is a widely expressed serine/threonine kinase that is activated by extracellular signal-regulated kinase 1/2 and phosphoinositide-dependent kinase 1 in response to many growth factors and peptide hormones. Its activation is known to be involved in proliferation and cell transformation induced by carcinogens. Kaempferol 3-O-(3 ,4 -di-O-acetyl--L-rhamnopyranoside), also known as compound SL0101 (Fig. 2) , was identified as the first specific inhibitor of this kinase (IC 50 = 89 nM) and was also found to suppress proliferation of MCF-7 breast cancer cells [156] . The related compound 3Ac-SL0101 also inhibited this kinase in LNCaP prostate cancer cells [157] . This activity has also been shown by its aglycone kaempferol [158, 159] . Kaempferol can also act as a weak estrogen receptor agonist and may cause estrogenic or antiestrogenic effects mainly depending on the concentration of endogenous estrogens. The antiestrogenic (and weak estrogenic) activity of kaempferol may result in inhibition of the growth of hormone-dependent cancers such as breast and prostate cancers [160] [161] [162] [163] . Kaempferol may also induce differentiation in colon cancer cells by reestablishing gap junctional intercellular communications, which are commonly impaired in cancer [164] .
In addition to having cancer chemopreventive properties, kaempferol has shown activities that may have relevance to cancer therapy. Numerous reports have shown that kaempferol and/or some kaempferol glycosides induce cell death in a variety of cancer cells from different tissues, including lung [124, [165] [166] [167] , breast [120, 122, 127, 161, 168, 169] , colon [159, 165, 170, 171] , prostate [120, 172, 173] , liver [154, 174] , pancreas [126] , blood/lymph [117, 123, [175] [176] [177] [178] [179] [180] [181] , skin [159, 165, 167, 176, 182, 183] , esophagus [184, 185] , brain [125, 165, 186] , uterus [182, 187] , ovary [155, 165, 188, 189] , thyroid [190] and bone [121] . Many of these reports have shown that kaempferol induces cell death through apoptosis, and the possible mechanisms involved in this process have been elucidated. Caspases are a family of cysteine proteases involved in the initiation and execution of apoptosis, and kaempferol has been found to induce the activation of caspase-3 [123, 125, 166, 170, 179, [184] [185] [186] 191] , caspase-7 [122, 124] and caspase-9 [122, 123, 179, 184, 185] . This flavonoid can also activate the apoptosis-inducing factor (AIF), which is involved in the initiation of a caspase-independent pathway of apoptosis [166] . Several studies have shown that kaempferol can decrease the antiapoptotic proteins Bcl-2 [123] [124] [125] 191] and Bcl-Xl [124] and increase the proapoptotic proteins Bax and Bad [122] [123] [124] . This dietary agent can also down-regulate the antiapoptotic protein Xlinked inhibitor of apoptosis protein (XIAP) [186] . Poli-ADP-ribose polymerase (PARP) activation, cytochrome c release and loss of mitochondrial membrane potential are important events in the induction of apoptosis, and kaempferol has been found to stimulate PARP [123, 125, 127, 179] and induce mitocondrial cytochrome c release and loss of mitochondrial membrane potential [123, 125, 170, 179, 186] . Filomeni et al. [192] have recently reported that kaempferol induces energetic failure due to inhibition of both glucose uptake and complex I of the mitochondrial respiratory chain; this results in the activation of autophagy, which may prevent to some extent the capacity of kaempferol to induce apoptosis.
Several other mechanisms may participate in kaempferolinduced cancer cell death. Kaempferol-induced apoptosis in cancer cells has been associated with its ability to inhibit the activity of fatty acid synthase (FAS), a lipogenic enzyme that is activated in cancer cells [120, 193] . The enzymes DNA topoisomerases I and II are the target of several anticancer drugs commonly used in the clinic (e.g. etoposide, doxorubicin, topotecan and irinotecan), and kaempferol has been found to inhibit topoisomerase I [194] and topoisomerase II [195, 196] . Kaempferol can induce cell cycle arrest at G2/M [117, 122, 172, 183, 185, 191, 197] , which may be mediated, for instance, by the inhibition of the activity of the cyclin-dependent kinase CDK1 [183] . Proteasomes are large protein complexes that degrade unneeded or damaged proteins by proteolysis; these complexes play an important function in regulating protein levels and are necessary for cell survival. Proteosoma inhibitors are a new class of anticancer agents (e.g. bortezomib) and kaempferol has been found to act as a proteasome inhibitor in human leukemia cells [198] . The antiproliferative effects of kaempferol in cancer cells may also be mediated by the inhibition of the MAPK/ERK pathway [124, 127, 186] . Finally, although low concentrations of kaempferol can reduce the cellular levels of ROS and induce antioxidant effects, higher concentrations of this flavonoid are known to generate ROS [123, 125, 179, 186] . The induction of ROS in cancer cells is emerging as an important anticancer strategy [138, [199] [200] [201] and may play an important role in the cytotoxic effects of kaempferol [123, 125, 127] .
Evidence suggests that kaempferol could be used in combination with several anticancer drugs to improve their therapeutic effects. It has been reported that kaempferol can sensitize cancer cells to the cytotoxic effects of cisplatin [189] , 5-fluorouracil [126] , cytarabine [202] , doxorubicin [125] , mitoxantrone and the active metabolite of irinotecan (SN-38) [203] . This flavonoid can also enhance the cytotoxic effects of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) [204, 205] . These investigations suggest that kaempferol may have clinical applications as adjuvant therapy in the treatment of some cancers.
Antimicrobial Activity
Flavonoids are known to play a protective role against microbial invasion in plants that synthesize these polyphenols. This protective role involves the presence of flavonoids in plants as constitutive agents as well as their accumulation as phytoalexins in response to microbial attack [206] . It is not surprising, therefore, that plants rich in flavonoids have been used for many years in traditional medicine to treat infectious diseases [207] . Kaempferol and its glycosides have been isolated from plants used in popular medicine for their antimicrobial properties. Numerous papers have reported that kaempferol, its glycosides, or plants containing kaempferol have antibacterial, antiviral, antifungal and antiprotozoal activities.
The antibacterial activity of kaempferol has been widely reported. 220] and it has been suggested that the hydroxyl groups at C3 and C4' are necessary for the inhibition of this enzyme [220] . This activity, along with its ability to inhibit viral proteases and binding of gp120 to lymphocytes CD4, may account for the anti-HIV activity of this flavonoid [219] . Jeong et al. [217] observed that some compounds isolated from Rhodiola rosea, including kaempferol, inhibited neuraminidase activity and showed high inhibitory activity against the influenza viral strains H1N1 and H9N2. Mitrocotsa et al.
[216] evaluated the antiviral activity of seven kaempferol derivatives against human cytomegalovirus and observed that the presence of acyl substituents markedly increased the activity; the most active compound was kaempferol-3-O--L-(2",3"-di-E-p-acetylcoumaroyl)-rhamnopyranoside.
Some studies have found that kaempferol interferes with enzymes that are vital for growth or virulence of certain fungi [221] [222] [223] [224] . Chitin is a structural polysaccharide of fungal cell walls, which is vital for its integrity and is synthesized by chitin synthase. Hwang et al. [221] carried out an in vitro study with several flavonoids and found that kaempferol and kaempferol-3-O-(2"-O-galloyl)--Dglucoside inhibited chitin synthase II and prevented fungal cell division. It has also been shown that kaempferol is able to inhibit melanin synthesis [223] ; melanin is a virulence factor in pathogenic fungi and a known target for antimycotic compounds. Yordanov et al. [222] found that kaempferol affected extracellular enzymes of Candida albicans, which are claimed to be virulence factors responsible for penetration of the yeast into host cells. Kaempferol administration to animals with systemic Candida albicans infection was found to increase the number of survivors. The authors also showed that the application of kaempferol in cutaneous infection suppressed the symptoms and accelerated the elimination of the yeast from the site of inoculation [222] . Kaempferol has also been described as an antiprotozoal agent [225] [226] [227] [228] . This flavonoid has shown activity against Leismania spp [229, 230] and is also active against Entamoeba histolytica and Giardia lamblia [227] , which are known to cause diarrhea. The antigiardial activity of kaempferol has been observed in vivo in female CD-1 mice infected with Giardia lamblia [225] .
Other Biological Activities
Several case-control and cohort studies evaluated the relationship between consumption of kaempferol-rich foods and the risk of developing or dying of cardiovascular diseases. These studies revealed that the consumption of kampferol-containing foods was associated with a reduced mortality from coronary heart disease [1] , with a weak risk reduction for coronary heart disease death [35] , with a reduced incidence of myocardial infarction [1, 34, 36], and with a lower incidence of cerebrovascular disease [37] . The protective role of kaempferol in cardiovascular diseases may be mediated by different mechanisms. Because oxidative stress [231] and inflammation [232] are known cardiovascular risk factors, it makes sense to think that the known antioxidant and anti-inflammatory properties of kaempferol may play a critical role in this protective effect. The ability of kaempferol to prevent atherosclerosis may be mediated, for instance, by its capacity to prevent the oxidation of the lipoproteins LDL [70-74]. Kaempferol has also been shown to inhibit angiotensin converting enzyme (which converts angiotensin I to angiotensin II and causes an elevation of blood pressure) [233] [234] [235] [236] , to induce vasodilator effects [237] [238] [239] , and to cause antiplatelet and antithrombotic effects [240, 241] . Kaempferol and some glycosides of kaempferol may also decrease triglycerides levels, cholesterol levels and/or reduce body weight [242] [243] [244] .
Evidence suggests that some kaempferol glycosides and several kaempferol-containing plants have antidiabetic activity [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] and may prevent diabetic complications [255, 256] . For instance, studies with kaempferol-3,7-O--dirhamnoside (kaempferitrin) and kaempferol 3-neohesperidoside (Fig. 2) , isolated from Cyathea phalerata stems, showed a significant hypoglycemic effect in diabetic rats [257] . This antidiabetic effect may be mediated by stimulation of glycogen synthesis, and Cazarolli et al. found that the phosphatidylinositol 3-kinase (PI3K)-glycogen synthase kinase 3 (GSK-3) pathway and the MAPK-protein phosphatase 1 (PP1) pathway were involved in the stimulatory effect of kaempferol 3-neohesperidoside on glycogen synthesis in rat soleus muscle [258] . This flavonoid was also found to induce a stimulatory effect on glucose uptake when the rat soleus muscle was incubated with very low concentrations of this kaempferol glycoside (1 and 100 nM) [259] . The authors also showed that 100 mg/kg of kaempferol 3-neohesperidoside administered by oral gavage was able to increase glycogen content in the muscle, and suggested that this flavonoid stimulates glucose uptake in the rat soleus muscle via the PI3K and PKC pathways [259] . The oral administration of kaempferitrin has also been found to induce a significant hypoglycemic effect in normal and in alloxan-induced diabetic rats [246] . A single oral administration of two extract from the aerial parts of 
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[678] Equisetum myriochaetum also reduced blood glucose levels in diabetic rats; the authors proposed that kaempferol-3-sophoroside-4'-O--D-glucoside was responsible for this activity [248] . The hypoglycemic effect of a water extract from the aerial parts of Equisetum myriochaetum was later evaluated in eleven type 2 diabetic patients [249] . The authors found that the oral administration of the extract (0.33 g/kg) significantly reduced blood glucose levels in these diabetic patients without significantly affecting insulin levels [249] . Fang et al. observed that kaempferol improved insulin-stimulated glucose uptake in mature adipocytes and suggested that this flavonoid could potentially act on multiple targets to ameliorate hyperglycemia, including the peroxisome proliferator-agonist receptor (PPAR ) [260] .
Kaempferol may also prevent the onset of diabetes by preventing oxidative damage in pancreatic cells [261] . All these studies support the idea that kaempferol, several glycosides of kaempferol and/or some kaempferolcontaining plants have potential to be developed as antidiabetic agents.
Phytoestrogens are a group of compounds from plant origin that share a similar structure with the estrogenic compound estradiol. These compounds can bind to the estrogen receptors and produce estrogenic effects, although these effects are weaker than those of 17 -estradiol. Because phytoestrogens compete with estrogens for the same receptors, phytoestrogens can act as estrogenic or antiestrogenic compounds mainly depending on the concentration of endogenous estrogens. When the levels of estrogens are low (e.g. after menopause), phytoestrogen act as estrogenic compounds and may relieve the menopause symptoms and cause beneficial effects on cardiovascular disease, osteoporosis, Alzheimer's disease, etc. When the levels of estrogens are not decreased, phytoestrogens act as antiestrogenic compounds and may be beneficial for preventing the development of some cancers that need estrogens for their growth, such as some breast and prostate cancers. Several reports have shown that kaempferol is a phytoestrogen that cause both estrogenic and antiestrogenic effects [161, 162, 262] . This flavonoid can bind to both subtypes of the estrogen receptor (ER), ER-and ER-, although it has been observed that the affinity of kaempferol for the ER-receptor is higher than for the ER-receptor [161, 162, [262] [263] [264] [265] . The hydroxyl group at C-4' seems crucial for the estrogenic activity of kaempferol [266] . The antiestrogenic (and weak estrogenic) activity of kaempferol may result in inhibition of the growth of homone-dependent cancers such as breast and prostate cancers [160] [161] [162] [163] . The estrogenic effects of kaempferol may be beneficial for women after menopause, when estrogen levels fall. It has been reported that kaempferol potentiated the uterotrophic effect of 17 -estradiol in immature and ovariectomized rats [267] and increased sensitivity of the uterus to estrogens in immature female mice [268] .
Kaempferol may exert a protective effect against postmenopausal bone loss, as it has been found to promote osteoblast mineralization in vitro and bone formation in vivo [269] [270] [271] [272] [273] [274] . Wattel et al. [269] observed that kaempferol, at concentrations ranging from 100 nM to 100 μM reduced bone resorption in a time and dose-dependent manner. The authors observed significant inhibitory effects at concentrations as low as 100 nM and reported data suggesting that the estrogenic activity of kaempferol could be involved in the inhibition of bone resorption [269] . Trivedi et al. [270] reported that kaempferol increased mineralized nodules in rat primary osteoblasts at concentrations from 0.2 to 5 μM. Daily oral administrations of kaempferol (5 mg/kg body weight) for 10 weeks to ovariectomized rats resulted in significantly higher bone mineral density (BMD) in the trabecular regions (femur neck, proximal tibia and vertebrae) and lower serum ALP (a bone turnover marker). Kaempferol treatment also caused an increase in osteoprogenitor cells as well as a reduction of adipocyte differentiation from bone marrow cells. The authors concluded that kaempferol exerts bone anabolic activity with attendant inhibition of bone marrow adipogenesis [270] . An extract of Ginkgo biloba, which contains kaempferol glycosides, was also found to restore bone mass in aged ovariectomized rats [271] .
Some in vitro and in vivo studies suggest that kaempferol, some glycosides of kaempferol and plants containing this flavonoid may have neuroprotective activity and play a protective role in the development of Alzheimer's disease, Parkinson's disease or Huntington's disease [275] [276] [277] [278] [279] [280] [281] [282] [283] . For instance, Lopez-Sanchez et al. [275] carried out an in vivo study to evaluate the neuroprotective effect of kaempferol and found that the intravenous administration of this dietary agent decreased ischemia-induced brain damage in rats. This protective effect was associated with the capacity of kaempferol to reduce metalloproteinase activation, to prevent protein nitrotyrosines accumulation and to protect against apoptotic cell death caused by oxidative stress [275] . Because oxidative stress is known to play an important role in some neurodegenerative disorders [40, 41] it makes sense to think that the antioxidant activity of kaempferol participates in its neuroprotective activity [284] . Other mechanisms, such as reduction in amyloid protein, may participate in the possible protective effect of kaempferol against Alzheimer's disease [279, [285] [286] [287] .
Several reports suggest that kaempferol, glycosides of kaemperol such as tiliroside (Fig. 2) and several kaempferolcontaining plants (e.g. Tilia species) have anxiolytic activity in vivo [288] [289] [290] [291] [292] . In vitro and in vivo studies have also reported that kaempferol have antiallergic and antiasthmatic activity [84, 97, [293] [294] [295] [296] [297] [298] , which may be mediated, at least in part, by inhibition of histamine release [97, 293, 294] . Analgesic activity has also been observed with several kaempferol glycosides and kaempferol-containing plants in numerous in vivo studies [79, 83, 85-88, 299-302].
Okamoto et al. [303] reported data suggesting that kaempferol could be useful for the treatment of cell mediated immune diseases, such as acute graft-versus-host disease (GVHD). The authors found that kaempferol acted directly on T cells and inhibited Th1 cytokine production, thus suppressing the expansion and generation of CD8 + cytotoxic T-lymphocytes in vitro. They also observed that C57BL/6-into-BDF1 mice treated with kaempferol for 1 week after acute GVHD induction showed reduced GVHD-associated anti-host CTL activity, induction of Th2 cell development, and host repopulation with donor lymphocytes, resulting in early restoration of body weight and increased survival [303] . Cortés et al. found that kaempferol inhibited IL-4-induced STAT6 activation by specifically targeting the tyrosine kinase JAK3 [304] . The authors discussed that this inhibitory effects of kaempferol could be useful in controlling T cell-dependent responses mediated by JAK3-dependent cytokines, and that the specific inhibition of JAK3 would result in a T cell immune suppression that could be useful in lymphoproliferative diseases with JAK3 abnormalities and in transplant rejection [304] .
PHARMACOKINETICS
Numerous in vitro studies have revealed that kaempferol has a wide range of biological activities. Some of these activities, however, may not be relevant in an in vivo setting if this flavonoid does not reach the target tissues at specific concentrations for a particular period of time. In other words, a low bioavailability and/or a high metabolism of kaempferol may be an obstacle for kaempferol to induce some bioactivities in vivo. Since kaempferol is a common dietary constituent and since the oral route is the preferred route of administration for most drugs, it is important to understand the fate of this flavonoid in the body when taken orally.
The pharmacokinetics of kaempferol has been studied in vitro and in vivo, both in rats and humans. An overview of the pharmacokinetics of kaempferol is illustrated in Fig. (3) . Flavonols such as kaempferol are commonly ingested as glycosides. It is recognized that the high polarity of glycosides hinders their absorption, whereas the intermediate polarity of aglycones facilitates it. Although this suggests that the absorption of glycosides needs the previous hydrolysis to absorbable aglycones, studies have shown that glycosides can be absorbed without hydrolysis [305] [306] [307] . Like other flavonoids, kaempferol is mainly absorbed in the small intestine. The lipophilicity of kaempferol facilitates its absorption by passive diffusion, but evidence suggests that it can also be absorbed by facilitated diffusion or active transport [308] . Kaempferol can be metabolized in the small intestine (to glucuronides and sulfoconjugates) by intestinal conjugation enzymes [308] . Like other flavonoids, kaempferol glycosides and kaempferol are extensively metabolized by the colon microflora. The colonic bacteria can both hydrolyze the glycosides to aglycones and break the C3 ring of aglycones to form simple phenolic compounds such as 4-hydroxyphenylacetic acid, phloroglucinol and 4-methylphenol, which can either be absorbed or excreted in feces [307, [309] [310] [311] [312] [313] [314] . After absorption, kaempferol is extensively metabolized in the liver to form glucurono-and sulfo-conjugated forms [308, 315, 316] . These conjugated forms of kaempferol, some phenolic compounds produced by the colon microflora, kaempferol and some kaempferol glycosides can reach systemic circulation and tissues and are then excreted in urine [270, [317] [318] [319] [320] [321] [322] [323] . The percentage of kaempferol excreted in urine has been found to be 1.9% [318] and 2.5% [321] of the total amount of kaempferol ingested.
Several human studies have demonstrated that, after oral ingestion, kaempferol is detected in plasma at nanomolar concentrations. Eight healthy volunteers received endive as a source of kaempferol (246 mg kaempferol/kg endive) [318] . A portion of endive, which contained 8.65 mg kaempferol in the form of kaempferol-3-glucuronide (79%), kaempferol-3-glucoside (14%) and kaempferol-3-(6-malonyl)-glucoside (7%), led to a mean maximum plasma concentration of 100 nM 5.8 h after oral ingestion. Radket et al. [322] measured the plasma concentrations of several flavonoids in 48 healthy women and found that the mean intake of kaempferol was 4.7 mg/day and that the corresponding mean plasma concentration was 10.7 nM. Cao et al. [324] undertook a dietary intervention study and reported that an estimated intake of 14.97 mg kaempferol/day led to a plasma concentration of 57.86 nM. An intake of 27 mg kaempferol from tea has also been reported to lead to a plasma concentration of 15 ng/ml (52 nM) [321] .
Some studies have found interconversions between kaempferol (3,5,7,4'-tetrahydroxyflavone) and the flavonoids galangin (3,5,7-trihydroxyflavone) and quercetin (3,5,7,3',4'-pentahydroxyflavone).
Galangin can be transformed to kaempferol by rat cytochrome P450 (CYP) via hydroxylation of the B-ring at C3' [325] . Nielsen et al. [326] found that kaempferol was metabolized to quercetin and that this effect was probably mediated by the enzymes CYP1A. Similar findings were reported by Breinholt et al. [327] . These data suggest that the biological activities of kaempferol could be observed after galangin ingestion, and that some of the effects induced by kaempferol in vivo might be mediated in part by quercetin, which is known to have a wide rage of biological activities [328, 329] .
As discussed previously, rodent and human studies have shown that the concentrations of kaempferol achieved in plasma and tissues after oral ingestion are in the nanomolar range. Although kaempferol has shown biological activities in this range, most of the effects described in the literature come from in vitro studies in which kaempferol was tested at micromolar concentrations. This suggests that, outside of the gastrointestinal tract, these effects may not be relevant in an in vivo setting when kaempferol is taken orally. Many in vivo studies discussed in this review have found, however, that kaempferol has different biological activities outside of the gastrointestinal tract when administered orally (e.g. antioxidant, anti-inflammatory, analgesic, antidiabetic, anticancer, etc). For instance, a recent study by Huang et al. [121] found that kaempferol inhibited the growth and induced apoptosis in human osteosarcoma U-2 OS cells in vitro, with an IC 50 of approximately 150 μM. The authors then observed that the oral administration of 25 or 50 mg/kg of kaempferol significantly reduced tumor weights and volumes in BALB/c (nu/nu) mice subcutaneously injected with U-2 OS cells [121] . Because the oral bioavailability of kaempferol is low, it is unlikely that the oral administration of kaempferol can lead to a concentration close to 150 μM in the U-2 OS cancer cells placed under the skin of the mice. This suggests that the tumor growth inhibition observed in mice after the oral administration of kaempferol [121] may be caused by metabolites of kaempferol or by an unknown indirect effect. The low oral bioavailability of kaempferol may be overcome by using alternative routes of administration, such as the i.v. route [275] .
SAFETY
There are conflicting reports regarding the safety of kaempferol. For example, although some studies have shown kaempferol to induce antimutagenic activity [114, 115, [330] [331] [332] , other reports have revealed that this flavonoid may induce genotoxic effects [117, [333] [334] [335] [336] [337] [338] [339] [340] [341] . The prooxidant activity of kaempferol may play an important role in these genotoxic effects. Although flavonoids are known antioxidants, these compounds can also act as prooxidant agents under specific conditions [56] . By hydrogen atom donation, a flavonoid can reduce a free radical and be transformed in a phenoxyl radical. This phenoxyl radical may either react with a second radical becoming stable (antioxidant effect), or interact with oxygen resulting in the generation of ROS (prooxidant effect) [44] . The prooxidant effects of flavonoids have also been attributed to their Fig. (3) . Overview of the pharmacokinetics of kaempferol (see text for details). K: kaempferol; KG: kaempferol glycosides; KCF: kaempferol conjugated forms; PA: phenolic acids; A: absorption, M: metabolism; E: excretion.
capacity of reducing iron and copper ions; these reduced metals may participate in the formation of hydroxyl radicals (e.g. Fenton reaction) and in lipid peroxidation [56, 66, 339] . Although the prooxidant effects of flavonoids have also been attributed to their capacity to autooxidize when they are dissolved in aqueous buffers, kaempferol did not show this capacity in a study performed by Canada et al. [342] . The prooxidant activity of kaempferol may also be mediated by its ability to modulate the levels or activity of antioxidant and prooxidant enzymes [340, 343] . Some reports suggest that the mutagenicity of kaempferol may also be caused by its transformation, by CYP 1A1 enzymes, to the more potent genotoxicant quercetin [337, 338] . Although numerous in vitro studies suggest that kaempferol and quercetin may be genotoxic and carcinogenic, these effects have not been demonstrated in animal studies [344] [345] [346] . For instance, Takanashi et al. [346] observed that the oral administration of quercetin (0.1%) and kaempferol (0.04%) in the diet for 540 days did not increase the incidences of tumors in rats [346] . The low oral bioavailability of kaempferol may prevent this flavonoid from reaching genotoxic concentrations in vivo.
Several reports suggest that kaempferol may cause other unwanted effects under specific conditions. Kaempferol can react with iron and reduce its bioavailability [347] or may decrease the cellular uptake of folic acid [348] ; these effects may cause problems in people with iron or folic acid deficiency.
Kaempferol may also increase the bioavailalability of the anticancer drug etoposide and increase its toxicity [349] or reduce the anticancer activity of cisplatin [350] . It is important to mention that, like other antioxidant/prooxidant polyphenols [351] , kaempferol can potentially increase or decrease the activity and toxicity of anticancer drugs with a prooxidant mechanism of action. At low concentrations, kaempferol may exert an antioxidant effect and reduce the activity of drugs that need to generate ROS to kill cancer cells efficiently. At high concentrations, kaempferol may generate ROS and increase the activity and toxicity of anticancer agents with a prooxidant mechanism. Because kaempferol has a low oral bioavailability, the ingestion of relatively high amounts of kaempferol leads to low concentrations of this flavonoid in plasma and tissues. These concentrations of kaempferol may cause antioxidant effects and can potentially reduce the activity of anticancer agents that need to generate ROS to exert their therapeutic effect.
CONCLUSIONS
Kaempferol is a flavonoid widely distributed in the plant kingdom. Numerous edible plants contain kaempferol, and it has been estimated that the human dietary intake of this polyphenol may be up to approximately 10 mg/day [28, 32, 352] . Epidemiological studies have found a positive association between the consumption of kaempferolcontaining foods and a reduced risk of developing cardiovascular diseases and some types of cancer. Numerous in vitro and some animal studies support a role of kaempferol in the prevention and/or treatment of these and other diseases, such as neurodegenerative diseases, infectious diseases, diabetes, osteoporosis, anxiety, allergies, inflammation and pain. However, many of these studies have been conducted at doses higher than those documented in humans and, therefore, it is difficult to predict from these results the effects of kaempferol intake on the prevention of these diseases. Likewise, most in vitro studies have been carried out at concentrations far beyond those achieved in plasma and tissues after the oral administration of kaempferol. This means that some biological effects induced by kaempferol in vitro, including some toxic effects, may not be relevant in vivo when this flavonoid is taken orally. The low oral bioavailability and high metabolism of kaempferol in humans should be overcome (e.g. by using alternative routes and forms of administration) to maximize some therapeutic properties of kaempferol. Additional animal studies and clinical trials are needed to better understand the possible health effects of kampferol and to further evaluate its potential as a new drug. 
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